Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Infectious Agents in Multiple Sclerosis: Viral Triggers, Antibody-Mediated Autoimmunity, and Parasitic Immunomodulation.
Racial identity, marginalization, and depression in pediatric-onset multiple sclerosis.
Extracellular vesicles from wild-type Epstein-Barr virus-transformed B-cells export host DNA and EBV EBER1.
Efficacy and safety of extended-interval dosing of natalizumab in multiple sclerosis: a systematic review and meta-analysis with subgroup evaluation.
Overexpression of human interleukin 6 in NaCl inducible bacterial system and its characterization.
The Spleen Negatively Regulates the Acute Phase of Experimental Autoimmune Encephalomyelitis in Mice.
Theory of Mind and Information Processing Speed in Multiple Sclerosis: Associations With Personality Traits.
Update on Selected Adverse Events of Concern Following Immunization With Acellular Pertussis Vaccines, a Narrative Review.
Ferritin-ApoE nanocarrier for targeted therapy of neuromyelitis optica spectrum disorder in mice.
Dietary intake and nutritional status in multiple sclerosis and associations with disease phenotype and management: A case-control study.
Global, regional, and national burden of road injuries 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
Keeping cool - how persons with MS manage heat sensitivity: Insights from the Swiss multiple sclerosis registry.
Exploring the Causal Role of Circulating Inflammatory Proteins in Multiple Sclerosis: A Mendelian Randomization Study and Druggability Analysis.
Biological and clinical stability after switching from intravenous to subcutaneous natalizumab in RRMS under standard and extended dosing.
MWF-MIMOSA for efficient simultaneous relaxometry and myelin water fraction mapping.
Treatment of multiple sclerosis with peptide-coupled red blood cells induces antigen-specific T regulatory cells.
HydroMEA: A 3D Hydrogel-Based Microfluidic Device to Study Electrophysiology for Myelinated Nerve-on-Chip.
Perspectives on End of Life and Medical Assistance in Dying From Saskatchewan People With Multiple Sclerosis.
Looking Beyond Dose: Identifying Responders and Non-Responders to RehaCom Computerized Cognitive Rehabilitation in Progressive MS-The CogEx Study.
Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4-IgG-Positive NMOSD.
Plasma Autoantibodies Against Neurodegeneration-Related Antigens in Dementia and Elevated Chi3Li Autoantibodies in Mild Cognitive Impairment.
Associations between Paramagnetic Rim Lesions and Gadolinium Contrast Permeability of Perivascular Spaces in Patients with Multiple Sclerosis: A T1 mapping study.
The design, synthesis and evaluation of the first carbon-11 positron emission tomography radiotracer for ASK1 imaging.
TOPSY: A picture description dataset to examine speech, language and communication in untreated first episode psychosis.
Discovery of 4-((2S,5R)-2-((difluoromethoxy)methyl)-5-(4-(trifluoromethyl)phenyl)piperidin-1-yl)-N-((R)-1-(4-(ethylsulfonyl)phenyl)-2-hydroxyethyl)benzamide as a potent, orally available RORγt inverse agonist.
Pages
« first
‹ previous
…
1020
1021
1022
1023
1024
1025
1026
1027
1028
…
next ›
last »